Neuroprotective effects of estrogens: potential mechanisms of action.
Epidemiological studies associate post-menopausal estrogen use with a reduction in risk of Alzheimer's disease, a reduction in risk of Parkinson's disease, and death from stroke. The neuroprotective efficacy of estrogens have been well described and may contribute to these clinical effects. Estrogen-mediated neuroprotection has been described in several neuronal culture model systems with toxicities including serum-deprivation, beta-amyloid-induced toxicity, excitotoxicity, and oxidative stress. In animal models, estrogens have been shown to attenuate neuronal death in rodent models of cerebral ischemia, traumatic injury, and Parkinson's disease. Although estrogens are known to exert several direct effects on neurons, the cellular mechanisms behind the neuroprotective efficacy of the steroid are only beginning to be elucidated. In this review, we summarize the data supporting a neuroprotective role for estrogens in both culture and animal models and discuss neuronal effects of estrogens that may contribute to the neuroprotective effects. These effects include activation of the nuclear estrogen receptor, altered expression of bcl-2 and related proteins, activation of the mitogen activated kinase pathway, activation of cAMP signal transduction pathways, modulation of intracellular calcium homeostasis, and direct antioxidant activity.
Green
P S
PS
Center for the Neurobiology of Aging, Department of Pharmcodynamics, University of Florida, Box 100487, JHMHC, Gainesville, USA.
Simpkins
J W
JW
D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects*; D004967:Estrogens / Q000378:metabolism* / Q000627:therapeutic use*; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D019636:Neurodegenerative Diseases / Q000188:drug therapy / Q000517:prevention & control*; D018696:Neuroprotective Agents / Q000378:metabolism* / Q000627:therapeutic use*
D004967:Estrogens; D018696:Neuroprotective Agents